Background Androgenetic alopecia (AGA) is one of the most common chronic problems seen by dermatologists worldwide. It is characterized by progressive hair loss, especially of scalp hair, and has distinctive patterns of loss in women versus men, but in both genders the central scalp is most severely affected. It often begins around puberty and is known to effect self-esteem and the individual's quality of life. In contrast to the high prevalence of AGA, approved therapeutic options are limited. In addition to the scarce pharmacologic treatments, there are numerous nonprescription products claimed to be effective in restoring hair in androgenetic alopecia. Objectives The purpose of this paper is to review published medical and non-medical treatments for male and female AGA using the American College of Physicians evidence assessment methods. MEDLINE, EMBASE and Cochrane Library were searched for systematic reviews, randomized controlled trials, open studies, case reports and relevant studies of the treatment of male and female AGA. The relevant articles were classified according to grade and level of evidence. Results The medical treatments with the best level of evidence classification for efficacy and safety for male AGA are oral finasteride and topical minoxidil solution. For female AGA, topical minoxidil solution appears to be the most effective and safe treatment. The medical treatments corresponding to the next level of evidence quality are some commonly used therapeutic non-FDA-approved options including oral and topical anti-hormonal treatments. Surgical treatment of follicular unit hair transplantation is an option in cases that have failed medical treatment although there is high variation in outcomes. Limitations Some articles, especially those concerning traditional herbs claimed to promote hair regrowth, were published in non-English, local journals. Conclusions An assessment of the evidence quality of current publications indicates that oral finasteride (for men only) and topical minoxidil (for men and women) are the best treatments of AGA.
机构:
Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, CanadaUniv British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
Banka, Nusrat M. D.
Bunagan, M. J. Kristine
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, CanadaUniv British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
Bunagan, M. J. Kristine
Shapiro, Jerry
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
NYU, Dept Dermatol, New York, NY 10016 USAUniv British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
机构:
US FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USAUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Bird, Steven T.
Brophy, James M.
论文数: 0引用数: 0
h-index: 0
机构:
McGill Univ, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, CanadaUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Brophy, James M.
Hartzema, Abraham G.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USAUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Hartzema, Abraham G.
Delaney, Joseph A. C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USAUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Delaney, Joseph A. C.
Etminan, Mahyar
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Child & Family Res Inst British Columbia, Vancouver, BC V5Z 1M9, CanadaUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
机构:
Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, CanadaUniv British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
Banka, Nusrat M. D.
Bunagan, M. J. Kristine
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, CanadaUniv British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
Bunagan, M. J. Kristine
Shapiro, Jerry
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
NYU, Dept Dermatol, New York, NY 10016 USAUniv British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 4E8, Canada
机构:
US FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USAUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Bird, Steven T.
Brophy, James M.
论文数: 0引用数: 0
h-index: 0
机构:
McGill Univ, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, CanadaUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Brophy, James M.
Hartzema, Abraham G.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USAUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Hartzema, Abraham G.
Delaney, Joseph A. C.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USAUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA
Delaney, Joseph A. C.
Etminan, Mahyar
论文数: 0引用数: 0
h-index: 0
机构:
Univ British Columbia, Child & Family Res Inst British Columbia, Vancouver, BC V5Z 1M9, CanadaUS FDA, US Dept HHS, Ctr Drug Evaluat & Res,Dept Epidemiol, Off Pharmacovigilance & Epidemiol,Off Surveillanc, Silver Spring, MD USA